Cerebrovascular Assessment for the Risk Prediction of Alzheimer's Disease

被引:30
|
作者
Silvestrini, Mauro [1 ]
Viticchi, Giovanna [1 ]
Altamura, Claudia [2 ]
Luzzi, Simona [1 ]
Balucani, Clotilde [3 ]
Vernieri, Fabrizio [2 ]
机构
[1] Univ Politecn Marche, Neurol Clin, I-60020 Ancona, Italy
[2] Campus Biomed Univ, Neurol Clin, Rome, Italy
[3] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA
关键词
Alzheimer's disease; vascular markers; vascular risk factors; WHITE-MATTER LESIONS; MILD COGNITIVE IMPAIRMENT; INTIMA-MEDIA THICKNESS; CEREBRAL VASOMOTOR REACTIVITY; GLYCATION END-PRODUCTS; MIDLIFE BLOOD-PRESSURE; APOLIPOPROTEIN-E; CAROTID ATHEROSCLEROSIS; AMYLOID-BETA; ATRIAL-FIBRILLATION;
D O I
10.3233/JAD-2012-121240
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Increasing evidence is emerging that vascular disease and its risk factors play a role in the development of Alzheimer's disease (AD) and affect the probability of an adverse outcome. The aims of this review are to explore the relationship between vascular risk factors and AD and to discuss the potential use of vascular markers in the clinical approach to cognitive impairment. Moreover, we present evidence about the potential use of ultrasonographic and neuroradiologic markers of cognitive impairment in order to establish possible treatment strategies in subjects with a clinical profile at risk of developing AD.
引用
收藏
页码:689 / 698
页数:10
相关论文
共 50 条
  • [41] The occurrence of cerebrovascular atherosclerosis in Alzheimer's disease patients
    Yuan, Jing
    Wen, Ge
    Li, Yingjia
    Liu, Changxing
    CLINICAL INTERVENTIONS IN AGING, 2013, 8 : 581 - 584
  • [42] Cerebrovascular muscle atrophy is a feature of Alzheimer's disease
    Perry, G
    Smith, MA
    McCann, CE
    Siedlak, SL
    Jones, PK
    Friedland, RP
    BRAIN RESEARCH, 1998, 791 (1-2) : 63 - 66
  • [43] Cerebrovascular Reactivity to Carbon Dioxide in Alzheimer's Disease
    Glodzik, Lidia
    Randall, Catherine
    Rusinek, Henry
    de Leon, Mony J.
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 35 (03) : 427 - 440
  • [44] Cerebrovascular Reactivity Impairment in Preclinical Alzheimer's Disease
    Alwatban, Mohammed
    Murman, Daniel L.
    Bashford, Greg
    JOURNAL OF NEUROIMAGING, 2019, 29 (04) : 493 - 498
  • [45] Cerebrovascular pathology in Alzheimer's disease: Hopes and gaps
    Badji, Atef
    Westman, Eric
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2020, 306
  • [46] Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology
    Abner, Erin L.
    Nelson, Peter T.
    Kryscio, Richard J.
    Schmitt, Frederick A.
    Fardo, David W.
    Woltjer, Randall L.
    Cairns, Nigel J.
    Yu, Lei
    Dodge, Hiroko H.
    Xiong, Chengjie
    Masaki, Kamal
    Tyas, Suzanne L.
    Bennett, David A.
    Schneider, Julie A.
    Arvanitakis, Zoe
    ALZHEIMERS & DEMENTIA, 2016, 12 (08) : 882 - 889
  • [47] Metabolic syndrome and cerebrovascular impairment in Alzheimer's disease
    Viticchi, Giovanna
    Falsetti, Lorenzo
    Buratti, Laura
    Luzzi, Simona
    Bartolini, Marco
    Acciarri, Maria Cristina
    Provinciali, Leandro
    Silvestrini, Mauro
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 30 (12) : 1164 - 1170
  • [48] Genetic risk assessment for adult children of people with Alzheimer's disease: The Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study
    Roberts, JS
    Cupples, LA
    Relkin, NR
    Whitehouse, PJ
    Green, RC
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2005, 18 (04) : 250 - 255
  • [49] Construction of a risk prediction model for Alzheimer's disease in the elderly population
    Wang, Lingling
    Li, Ping
    Hou, Ming
    Zhang, Xiumin
    Cao, Xiaolin
    Li, Hongyan
    BMC NEUROLOGY, 2021, 21 (01)
  • [50] Polygenic Risk Scores and Epistatic Components for Alzheimer's Disease Prediction
    Sun, Rui
    Xia, Xiaoxuan
    Wang, Maggie H.
    GENETIC EPIDEMIOLOGY, 2019, 43 (07) : 911 - 912